Denosumab in the Prevention of Skeletal-Related Events in Patients with Bone Metastases from Solid Tumors†: Profile Report

By Scott Lesley J.   Muir Victoria J.  

BioDrugs, Vol. 25, Iss. 6, 2011-12 ,pp. : 397-400

Adis International

Access to resources Recommend Favorite

Population Pharmacokinetic Analysis of Denosumab in Patients with Bone Metastases from Solid Tumours

By Gibiansky Leonid  

Clinical Pharmacokinetics, Vol. 51, Iss. 4, 2012-04 ,pp. : 247-260

Adis International

Access to resources Recommend Favorite

Denosumab: In the Prevention of Skeletal-Related Events in Patients with Bone Metastases from Solid Tumours

By Scott Lesley J.   Muir Victoria J.  

Drugs, Vol. 71, Iss. 8, 2011-05 ,pp. : 1059-1069

Adis International

Access to resources Recommend Favorite

Clinical and radiological evaluation of patients with lytic, mixed and sclerotic bone metastases from solid tumors: is there a correlation between clinical status of patients and type of bone metastases?

By Vassiliou Vassilios   Kalogeropoulou Christine   Petsas Theodoros   Leotsinidis Michael   Kardamakis Dimitrios  

Clinical and Experimental Metastasis, Vol. 24, Iss. 1, 2007-03 ,pp. : 49-56

Springer Publishing Company

Access to resources Recommend Favorite

Prevalence of renal impairment and use of nephrotoxic agents among patients with bone metastases from solid tumors in the United States

By  

Cancer Medicine, Vol. 4, Iss. 5, 2015-05 ,pp. : 713-720

John Wiley & Sons Inc

Access to resources Recommend Favorite